| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851924 | American Journal of Kidney Diseases | 2007 | 10 Pages |
Abstract
The hypothesis that prescribing aspirin to hemodialysis patients decreases cardiovascular disease risk is not supported. Aspirin might decrease CVA and appears not to increase hemorrhagic risk. This should be an incentive for randomized controlled trials.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jean MD, Jennifer L. MS, Luis MD, Tadao MD, Yasushi MD, PhD, Nancy PharmD, Brenda W. PhD, Eric W. MD, MS,